Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 16 March 2001:
Vol. 291. no. 5511, pp. 2060 - 2061
DOI: 10.1126/science.291.5511.2060b
Prev | Table of Contents | Next

News of the Week

PARKINSON'S RESEARCH:
Fetal Cell Transplant Trial Draws Fire

Gretchen Vogel

In just 1 week, an experimental treatment for Parkinson's disease--fetal cell transplants--went from promising to perilous. At least, that's how much of the general media reported the publication of mixed results from the first double-blind study. But Parkinson's researchers caution that results from a single trial, especially one that was controversial from the start, should not be the final word on the technique.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)